Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype

Cytometry Part A

Volumn 73, Issue 10, 2008, Pages 940-948

  Srivastava, Vinit Krishna ^a   Nalbantoglu, Josephine ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer stem cell; CD133; Flow cytometry; Medulloblastoma; Side population; Tumour sphere

Indexed keywords

CARBOXYFLUORESCEIN; CD133 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL PROLIFERATION; CELL SIZE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD; BENZIMIDAZOLES; CELL LINE, TUMOR; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCEINS; GLYCOPROTEINS; HUMANS; MEDULLOBLASTOMA; NEOPLASTIC STEM CELLS; PEPTIDES; SPHEROIDS, CELLULAR; SUCCINIMIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 53049089115     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20633     Document Type: Article

References (23)

1. Hanahan D, Weinberg RA. The hallmarks of Cancer. Cell 2000;100:57-70.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
3. Li L, Neaves WB, Normal Stem Cells and Cancer Stem Cells: The Niche Matters. Cancer Res 2006;66:4553-4557.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
5. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJA. The origin of the cancer stem cell: Current controversies and new insights. Nat Rev Cancer 2005;5:899-904.
6. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648.
7. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
8. Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 2007;67:1-5.
9. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li Y-M, Eberhart CG. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445-7452.
10. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004;101:781-786.
11. Bellows CG, Aubin JE. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev Biol 1989;133:8-13.
12. Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 1999;208:166-188.
13. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-284.
14. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.
15. Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA 2002;99:12339-12344.
16. Jonker JW, Buitelaar M, Wagenaar E, van der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RPJO, Rosing H and others. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 2002;99:15649-15654.
17. Bertoncello I, Hodgson GS, Bradley TR. Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol 1985;13:999-1006.
18. Steuer B, Breuer B, Alonso A. Differentiation of EC cells in vitro by the fluorescent dye Hoechst 33342. Exp Cell Res 1990;186:149-157.
19. Adamski D, Mayol J-F, Platet N, Berger F, Hérodin F, Wion D. Effects of Hoechst 33342 on C2C12 and PC12 cell differentiation. FEBS Lett 2007;581:3076-3080.
20. Platet N, Mayol J-F, Berger F, Hérodin F, Wion D. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett 2007;581:1435-1440.
21. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
22. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100:15178-15183.
23. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: Evidence from clonal and population analyses. Cancer Res 2007;67:3691-3697.